Table 2B:
Frequency of SNP rs1910301 across the study populations
| GG | AG | AA | A Allele Frequency | ||
|---|---|---|---|---|---|
| PHS/PFS 1 | Mets or PrCa2 death (event) | 106 (32.4) | 69 (34.3) | 21 (58.3) | 28.3% |
| No Mets or prostate cancer death | 221 (67.6) | 132 (65.7) | 15 (41.7) | 22.0% | |
| ECOG 1 | Mets or PrCa death (event) | 140 (46.4) | 96 (55.2) | 20 (58.8) | 26.5% |
| Gelb Center 1 | No Mets or PrCa death | 162 (53.6) | 78 (44.8) | 14 (41.2) | 20.8% |
| Fred Hutch 1 | Mets or PrCa death | 57 (13.7) | 37 (17.1) | 10 (23.3) | 27.4% |
| No Mets or PrCa death | 358 (86.3) | 179 (82.9) | 33 (76.7) | 21.4% | |
| PRACTICAL | GG | AG | AA | ||
| European descent | Cases | 32451 (58.8) | 19585 (35.5) | 3126 (5.7) | 23.4% |
| Controls | 21085 (58.3) | 12994 (35.9) | 2068 (5.7) | 23.7% | |
| Asian Descent | Cases | 707 (57.6) | 447 (36.4) | 74 (6.0) | 24.2% |
| Control | 702 (58.0) | 437 (36.1) | 70 (5.8) | 23.9% | |
| African Descent | Cases | 721 (16.9) | 1943 (45.5) | 1603 (37.6) | 60.3% |
| Controls | 685 (17.1) | 1879 (46.8) | 1449 (36.1) | 59.5% |
1
All self-identified Caucasian
2
PrCa: prostate cancer